UA91497C2 - ЗАСТОСУВАННЯ ПЕПТИДІВ, ВИДІЛЕНИХ З ЛАНЦЮГА Bβ ЛЮДСЬКОГО ФІБРИНОГЕНУ, ДЛЯ ЛІКУВАННЯ ШОКУ - Google Patents
ЗАСТОСУВАННЯ ПЕПТИДІВ, ВИДІЛЕНИХ З ЛАНЦЮГА Bβ ЛЮДСЬКОГО ФІБРИНОГЕНУ, ДЛЯ ЛІКУВАННЯ ШОКУInfo
- Publication number
- UA91497C2 UA91497C2 UAA200604047A UAA200604047A UA91497C2 UA 91497 C2 UA91497 C2 UA 91497C2 UA A200604047 A UAA200604047 A UA A200604047A UA A200604047 A UAA200604047 A UA A200604047A UA 91497 C2 UA91497 C2 UA 91497C2
- Authority
- UA
- Ukraine
- Prior art keywords
- moiety
- denotes
- shock
- peptide
- alpha
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 230000035939 shock Effects 0.000 title abstract 2
- 229940106780 human fibrinogen Drugs 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 102000009123 Fibrin Human genes 0.000 abstract 2
- 108010073385 Fibrin Proteins 0.000 abstract 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 abstract 2
- 229950003499 fibrin Drugs 0.000 abstract 2
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract 1
- 102000008790 VE-cadherin Human genes 0.000 abstract 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 108010018828 cadherin 5 Proteins 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 229930195734 saturated hydrocarbon Natural products 0.000 abstract 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Винахід належить до застосування пептиду загальної формули IIдеRта R, однакові або різні, представляють водень, насичену або ненасичену вуглеводневу частину, яка містить від 1 до 10 атомів вуглецю,Z- гістидинова або пролінова частина,Arg - аргінінова частина,Z- пролінова або валінова частина,Z- лейцинова або валінова частина,Z- пептидна частина, одержана з ланцюга Вβ фібрину,причому пептид біологічно здатний відповідати індукованій зв'язуючій VE-кадгерин частині ланцюга Вβ (тобто Вβ) людського фібрину, для виготовлення фармацевтичного препарату для лікування шоку.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0108704A AT414097B (de) | 2004-06-25 | 2004-06-25 | Pharmazeutische zubereitung zur behandlung von schock |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA91497C2 true UA91497C2 (uk) | 2010-08-10 |
Family
ID=35508712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200604047A UA91497C2 (uk) | 2004-06-25 | 2005-06-24 | ЗАСТОСУВАННЯ ПЕПТИДІВ, ВИДІЛЕНИХ З ЛАНЦЮГА Bβ ЛЮДСЬКОГО ФІБРИНОГЕНУ, ДЛЯ ЛІКУВАННЯ ШОКУ |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN1842344A (uk) |
| AT (1) | AT414097B (uk) |
| UA (1) | UA91497C2 (uk) |
| ZA (1) | ZA200602053B (uk) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT502987A1 (de) | 2005-12-23 | 2007-07-15 | Fibrex Medical Res & Dev Gmbh | Pharmazeutische zusammensetzung zur behandlung von hämorrhagischem schock und seinen folgeerscheinungen |
| CN101937002A (zh) * | 2010-07-23 | 2011-01-05 | 合肥天一生物技术研究所 | 血红蛋白目测试剂 |
| EP2844270A4 (en) * | 2012-03-15 | 2016-01-27 | Univ New York State Res Found | COMBINATION THERAPIES WITH INHIBITORS OF THE EXTRACELLULAR DOMAIN OF E-CADHERINE |
| EP3912679A1 (en) * | 2020-05-19 | 2021-11-24 | Johann Wolfgang Goethe-Universität Frankfurt am Main | Bbeta-15-42 for the treatment of viral endothelitis |
-
2004
- 2004-06-25 AT AT0108704A patent/AT414097B/de not_active IP Right Cessation
-
2005
- 2005-06-24 ZA ZA200602053A patent/ZA200602053B/en unknown
- 2005-06-24 CN CNA2005800009931A patent/CN1842344A/zh active Pending
- 2005-06-24 UA UAA200604047A patent/UA91497C2/uk unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200602053B (en) | 2007-06-27 |
| CN1842344A (zh) | 2006-10-04 |
| AT414097B (de) | 2006-09-15 |
| ATA10872004A (de) | 2005-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109631T1 (el) | Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ | |
| DK0750506T3 (da) | Bredspektrede, antimikrobielle forbindelser og fremgangsmåder til anvendelse af disse | |
| NZ593815A (en) | Tissue factor pathway inhibitor (tfpi) inhibitors and methods of use | |
| AR062065A1 (es) | Anticuerpo humanizado | |
| AR036196A1 (es) | Agentes de contraste multimericos dirigidos a base de peptidos | |
| WO2009004315A8 (en) | Isolated peptides and uses thereof | |
| CY1111225T1 (el) | Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c | |
| WO2005116051A3 (de) | An mhc-moleküle bindende tumor-assoziierte peptide | |
| AU2003264419A1 (en) | Kdr peptides and vaccines containing the same | |
| DK2231860T3 (da) | Polypeptid afledt protein A og i stand til at binde PDGF | |
| WO2006113681A3 (en) | Plant-derived elastin binding protein ligands and methods of using the same | |
| YU53803A (sh) | Peptidi i/ili proteini kao i njihova primena za pripremanje terapeutskih i/ili preventivnih lekova | |
| ATE455792T1 (de) | Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon | |
| MXPA05008080A (es) | Inhibidores peptidicos de toxinas derivadas de la ll-37. | |
| UA91497C2 (uk) | ЗАСТОСУВАННЯ ПЕПТИДІВ, ВИДІЛЕНИХ З ЛАНЦЮГА Bβ ЛЮДСЬКОГО ФІБРИНОГЕНУ, ДЛЯ ЛІКУВАННЯ ШОКУ | |
| ATE532502T1 (de) | Kosmetische zusammensetzung für das haar | |
| WO2005097828A3 (en) | Peptides of cav2.2 that inhibit pain | |
| WO2007013358A3 (en) | Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent | |
| PL1625152T3 (pl) | Peptydy modelujące aktywność czynnika transkrypcyjnego Engrailed | |
| WO2022200327A3 (de) | Verwendung von d-enantiomeren peptidliganden von monomerem a-synuclein für die therapie verschiedener synucleinopathien | |
| AR026068A1 (es) | Peptidos modificados y peptidomimeticos para el uso en inmunoterapia. | |
| ATE538806T1 (de) | Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren | |
| WO2005087809B1 (en) | Peptides from vitronectin and their therapeutic exploitation for osteoblast adhesion | |
| WO2007066018A3 (fr) | Peptides qui peuvent se lier a la proteine nef et leurs applications pharmaceutiques | |
| ATE492637T1 (de) | An die lck-sh3 und hck-sh3 domäne bindende peptide |